Navigation Links
New Treatment Eyed for Hepatitis C
Date:1/20/2010

Class of compounds identified that inhibits viral growth in lab tests

WEDNESDAY, Jan. 20 (HealthDay News) -- A new class of compounds is able to inhibit replication of the hepatitis C virus (HCV) in laboratory tests, say U.S. scientists.

If they prove effective in humans, these compounds may offer an important new treatment option for patients infected with HCV, according to the Stanford University School of Medicine researchers. Current treatments for hepatitis C are only partially effective and often toxic.

HCV "infects over 150 million people worldwide, many of whom don't even know they have it. Chronic hepatitis C infection is the No. 1 cause of liver cancer and liver transplantation in the United States," study senior author Dr. Jeffrey Glenn, associate professor of gastroenterology and hepatology and director of Stanford's Center for Hepatitis and Liver Tissue Engineering, said in a news release.

The new class of compounds disrupts HCV's replication cycle by interfering with a process that doesn't ordinarily occur in uninfected cells. This means that HCV replication can be stopped with little or no toxicity to human cells.

The study was published online Jan. 20 in the journal Science Translational Medicine.

It could take a year to 18 months of preclinical and animal testing before these new compounds can be tested in human clinical trials, Glenn said.

He and his colleagues have equity in a privately held company to which Stanford has licensed intellectual property relevant to the new compounds.

More information

The American Academy of Family Physicians has more about hepatitis C.



-- Robert Preidt



SOURCE: Stanford University, news release, Jan. 20, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. New treatment boosts muscle function in myasthenia gravis
3. Broad-based group of physicians calls for improvement in stroke treatment
4. Cranberry Could Juice Up Ovarian Cancer Treatment
5. Non-medicinal treatment touted for pre-schoolers with ADHD
6. Nonmedicinal treatment touted for preschoolers with ADHD
7. U of M study: Early treatment can reverse heart damage
8. Biologic treatment for rheumatoid arthritis and the risk of cancer
9. New Treatment Explored for Cluster Headaches
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. 4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote Recovery Happens! Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: